The global market for the Botulinum Toxin is anticipated to develop at a compound annual growth rate (CAGR) of 11.8% throughout the course of the forecast, to reach $6,500 Million by 2030.
Growth in the occurrence of the cervical dystonia, spasticity and the patients of migraine is anticipated to fuel the global botulinum toxin market over the forecast period. Increase in the procedures of non-surgical botulinum toxin because of minimal or noninvasive nature is fueling the botulinum toxin industry. Surge in the elderly population and the prevalence of the esthetic issues like lateral canthal lines and crow’s foot is the factor that is expected to increase the botulinum toxin market in the coming years.
Scarcity of the awareness related to the developments in the therapeutic and non-surgical esthetic procedures is the main factor that is hindering the botulinum toxin market in terms of generation of revenue. Increase in the botulinum toxin market is because of several factors like immediate results, short time procedure and increase the comfort of patient. Rise in the spending on healthcare, increase in the procedures of facial aesthetics, growing substitute of non-surgical procedures, accelerating the number of surgeons and ageing population are the drivers responsible for the growth of botulinum toxin market. In spite of the botulinum toxin market is administered by several growth factors, assured challenges are tackled by the botulinum toxin market like potential health risk related to botulinum toxin as threat for bio-terror.
Fast growth of the industry is accredited to the increasing demand for the non-invasive and minimally invasive procedures that offers benefits like rapid wound healing, less hospital stay and small incision are moving towards increasing the demand of botulinum toxin market. Moreover, accessibility of the large range of non-invasive or minimally invasive options of treatment is influencing the botulinum toxin market growth.
Moreover, Necrotizing Fasciitis is uncommon form of the deadly disease that eats on human flesh and can be dangerous to humans if not diagnosed and treated at a correct time. This is caused by several strains of bacteria and spreads skin infection through body and reduces the ability of body to fight against infection. Current research specifies that controlling the botulinum toxin to the patients having the Necrotizing Fasciitis supports to block the nerve signals and limit the spread of the infection. The main role of botulinum toxin in curing the chronic infections is portion of innovation and new research studies and is expected to expand the botulinum toxin market growth in terms of revenue over the forecast period.
Global botulinum toxin market is segmented into distribution channel, application, product type and region. On considering the distribution channel, botulinum toxin market is divided into online pharmacies, retail pharmacies and hospital pharmacies. Based on application, market is divided into spasticity, chronic migraines, dystonia, cosmetics and more. On the basis of product type, market is divided into botulinum toxin type A and botulinum toxin type B.
Geographically, regions involved in the development of global botulinum toxin market are Europe, North America, Asia Pacific, Latin America and Middle East & Africa. North America is dominating the botulinum toxin market because of growing trend of the procedures of cosmetic in these regions. Asia Pacific is anticipated to show the fast growth in approving the innovative products and R&D in the coming years.
Key players involved in the botulinum toxin market are Ipsen Group, Allergan, Lanzhou Institute of Biological Products and more.
Botulinum Toxin Market Scope
| Metrics | Details |
| Base Year | 2022 |
| Historic Data | 2020-2021 |
| Forecast Period | 2022-2030 |
| Study Period | 2020-2030 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2030 | $6,500 Million |
| Growth Rate | CAGR of 11.8% during 2021-2030 |
| Segment Covered | End-Users, Regions |
| Regions Covered | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Key Players Profiled | Lanzhou Institute of Biological Products Co. Ltd., Merz Pharma GmbH & Co. KgaA, US Worldmed LLC, Allergan, Inc., Revance Therapeutics, Inc., Ipsen Group, Medytox, Inc., Nestlé Skin Health, Hugel Inc., AbbVie Inc. (Allergan), Galderma, and Evolus, Inc. and Metabiologics, Inc. |
Key Segments in the “Global Botulinum Toxin Market” are-
By Distribution Channel, market is segmented into:
- Online pharmacies
- Retail pharmacies
- Hospital pharmacies
By Application, market is segmented into:
- Spasticity
- Chronic migraines
- Dystonia
- Cosmetics
- Others
By Product Type, market is segmented into:
- Botulinum toxin type A
- Botulinum toxin type B
By Regions market is segmented into:
- Europe
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions (FAQ) :
The application of the botulinum toxin market Spasticity, Chronic migraines, Dystonia, Cosmetics and other.
Ipsen Group, Allergan, Lanzhou Institute of Biological Products are a few major players in botulinum toxin market.
To get latest version of botulinum toxin market report can be obtained on demand from the website.